Why the study?
To compare health utilization among atrial fibrillation patients undergoing ablation with a contact force-sensing catheter versus a cryoballoon catheter.
Does ablation with a contact force-sensing catheter reduce health utilization costs and readmissions compared to a cryoballoon catheter in atrial fibrillation patients?
Does ablation with a contact force-sensing catheter reduce health utilization costs and readmissions compared to a cryoballoon catheter in atrial fibrillation patients?
Contact force-sensing radiofrequency catheters may be associated with lower healthcare costs and readmission rates compared to cryoballoon catheters for atrial fibrillation ablation.
CF-sensing catheters were associated with lower costs than cryoballoon in AF ablation; hypothesis-generating and should not yet change practice.
AIM: To compare health utilization among atrial fibrillation (AF) patients undergoing ablation with a contact force-sensing (CF) catheter versus a cryoballoon (CB) catheter. METHODS: catheter) or CB catheter (Arctic Front™/Arctic Front Advance™ catheter) were identified from the Premier Healthcare database. Propensity score analyses were used to evaluate cost, length of stay and readmissions. RESULTS: The CF catheter (n = 1409) was associated with significantly lower total (∼7%) and supply (∼13%) costs and a significantly lower likelihood of 4-12 month all-cause and CV-related readmission compared with the CB catheter (n = 2306). CONCLUSION: Differential health utilization outcomes are associated with the CF catheter versus the CB catheter in AF ablation.
No takes yet. Share an insight, caveat, or question.
Pollak et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: